ChristopherLindMD

Biliary Tract Disease, Esophagus Disease, Gastrointestinal Functional & Motility Disorders

Professor, Medicine, Vanderbilt University School of Medicine

Dr. Lind is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

America's Top Doctors Castle Connolly, 2004-2014
Nashville Lifestyles Magazine Castle Connolly, 2006, 2013-2014
Fellow (AGAF) American Gastroenterological Association, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACP) American College of Physicians, 2006
Top MD Consumers Checkbook
Join now to see all

PubMed

116 citations
Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement.
Christopher D. Lind, Tim W. Malisch, Wui Kheong Chong, William O. Richards, C. Wright Pinson
Gastroenterology. 1994-05-01
45 citations
Efficacy of Cetuximab in the Treatment of Ménétrier’s Disease
William H. Fiske, Jarred P. Tanksley, Ki Taek Nam, James R. Goldenring, Robbert J.C. Slebos
Science Translational Medicine. 2009-11-25
57 citations
Distinguishing Ménétrier’s Disease from its Mimics
Amy Rich, Tania Zuluaga Toro, Jarred P. Tanksley, William H. Fiske, Christopher D. Lind
Gut. 2010-12-01